Atrial Fibrillation Progression Trial (ATTEST)
Sponsor: Biosense Webster, Inc.
Terminated
The sponsor decided to terminate the study early due to enrolment not proceeding in accordance with expectations, independently from the study outcome.
Other terminated trials from Biosense Webster, Inc.
- Non-ischemic Cardiomyopathy · Nov 2024
- Ventricular Tachycardia · Phase EARLY_PHASE1 · Oct 2024
- Stroke · Phase PHASE3 · Dec 2023
- Atrial Fibrillation · Phase NA · Jun 2023
- Paroxysmal Atrial Fibrillation · Phase NA · Oct 2022
More terminations from Biosense Webster, Inc.
Other Atrial Fibrillation trials with similar outcome
Listed as NCT01570361, this PHASE4 trial focuses on Atrial Fibrillation and remains terminated or withdrawn. Sponsored by Biosense Webster, Inc., it has been updated 12 times since 2012, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
12 versions recorded-
Mar 2025 — Present [monthly]
Terminated PHASE4
-
Sep 2024 — Mar 2025 [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE4
▶ Show 7 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Terminated PHASE4
-
Jun 2020 — Nov 2020 [monthly]
Terminated PHASE4
Status: Completed → Terminated
-
Jun 2019 — Jun 2020 [monthly]
Completed PHASE4
-
Apr 2019 — Jun 2019 [monthly]
Completed PHASE4
-
Jul 2018 — Apr 2019 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE4
First recorded
Feb 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Biosense Webster, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.